The growing need for supportive cancer care is creating opportunities in the Neulasta Pegfilgrastim And Biosimilar Market. Pegfilgrastim is a long-acting granulocyte colony-stimulating factor used to support patients receiving certain chemotherapy treatments. According to a recent report by Wise Guys Report, market development is influenced by increasing cancer treatment volumes, demand for...